Prenetics Global (PRE) Competitors

Prenetics Global (NASDAQ:PRE) and 908 Devices (NASDAQ:MASS) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, earnings, institutional ownership, profitability, community ranking, valuation and risk.

Is PRE or MASS more profitable?

908 Devices has a net margin of -109.11% compared to Prenetics Global's net margin of -191.73%. Prenetics Global's return on equity of -16.45% beat 908 Devices' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Prenetics Global	-191.73%	-16.45%	-13.34%
908 Devices	-109.11%	-24.60%	-19.23%

Which has more risk & volatility, PRE or MASS?

Prenetics Global has a beta of -0.31, meaning that its stock price is 131% less volatile than the S&P 500. Comparatively, 908 Devices has a beta of 0.99, meaning that its stock price is 1% less volatile than the S&P 500.

Do institutionals & insiders hold more shares of PRE or MASS?

25.0% of Prenetics Global shares are held by institutional investors. Comparatively, 88.1% of 908 Devices shares are held by institutional investors. 7.8% of Prenetics Global shares are held by insiders. Comparatively, 27.7% of 908 Devices shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Does the media refer more to PRE or MASS?

In the previous week, Prenetics Global and Prenetics Global both had 4 articles in the media. Prenetics Global's average media sentiment score of 1.08 beat 908 Devices' score of 0.83 indicating that Prenetics Global is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Prenetics Global	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
908 Devices	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts rate PRE or MASS?

Prenetics Global presently has a consensus target price of $9.00, suggesting a potential upside of 134.07%. 908 Devices has a consensus target price of $5.33, suggesting a potential upside of 31.69%. Given Prenetics Global's stronger consensus rating and higher possible upside, analysts plainly believe Prenetics Global is more favorable than 908 Devices.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Prenetics Global	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
908 Devices	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50

Which has stronger earnings & valuation, PRE or MASS?

908 Devices has higher revenue and earnings than Prenetics Global. 908 Devices is trading at a lower price-to-earnings ratio than Prenetics Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Prenetics Global	$25.56M	1.84	-$62.72M	-$3.99	-0.96
908 Devices	$59.63M	2.40	-$36.40M	-$2.10	-1.93

Does the MarketBeat Community favor PRE or MASS?

908 Devices received 12 more outperform votes than Prenetics Global when rated by MarketBeat users. However, 87.50% of users gave Prenetics Global an outperform vote while only 51.35% of users gave 908 Devices an outperform vote.

Company	Underperform	Outperform
Prenetics Global	Outperform Votes 7 87.50%	Underperform Votes 1 12.50%
908 Devices	Outperform Votes 19 51.35%	Underperform Votes 18 48.65%

Summary

908 Devices beats Prenetics Global on 10 of the 17 factors compared between the two stocks.